Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Infectious Diseases

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/cir764PMID 22109947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IDSA GUIDELINES Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children

  2011cited by this paper
• Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1

  2011cited by this paper
• Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).

  2010cited by this paper
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.

  2010cited by this paper
• Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus

  2009cited by this paper
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

  2009cited by this paper
• Therapeutic Monitoring of Vancomycin in Adults

  2009cited by this paper
• Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

  2008cited by this paper
• Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

  2008cited by this paper
• Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

  2008cited by this paper
• Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates

  2008cited by this paper
• Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

  2008cited by this paper
• Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.

  2008cited by this paper
• Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Urban Detroit

  2008cited by this paper
• Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.

  2007cited by this paper
• Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

  2006cited by this paper
• Community-associated Methicillin-resistant Staphylococcus aureus and Healthcare Risk Factors

  2006cited by this paper
• High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

  2006cited by this paper
• Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

  2006cited by this paper
• Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

  2004cited by this paper
• Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.

  2003cited by this paper
• Vancomycin resistant Staphylococcus aureus in the United States

  2002cited by this paper
• In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains

  2000cited by this paper
• Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

  1999cited by this paper
• Outcome Assessment of Minimizing Vancomycin Monitoring and Dosing Adjustments

  1999cited by this paper
• Surveillance of nosocomial infections

  1989cited by this paper
• Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study.

  1986cited by this paper
• Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak.

  1982cited by this paper

• The Evolving Landscape of Infective Endocarditis: Difficult-to-Treat Resistance Bacteria and Novel Diagnostics at the Foreground

  2025cites this paper
• Research Progress in the Treatment of Pediatric Staphylococcus aureus Bloodstream Infection

  2025cites this paper
• Multiresistente Erreger in der Kinder- und Jugendmedizin

  2025cites this paper
• Antibioticoterapia probabilista en reanimación

  2025cites this paper
• Terapia antibiotica probabilistica in rianimazione

  2025cites this paper
• Influence of renal function and daptomycin dose on clinical effectiveness and adverse events in Japanese pediatric patients: A multicenter retrospective observational study

  2025cites this paper
• Antibiothérapie probabiliste en réanimation

  2025cites this paper
• Antibiothérapie et antibioprophylaxie de l'endocardite infectieuse – Une prise de position SPILF-AEPEI sur les recommandations 2023 de l'ESC

  2024cites this paper
• Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens

  2024cites this paper
• Photodynamic inactivation of antibiotic-resistant bacteria in whole blood using riboflavin photodynamic method

  2024cites this paper
• Assessment of carvacrol-antibiotic combinations’ antimicrobial activity against methicillin-resistant Staphylococcus aureus

  2024cites this paper
• Staphylococcus aureus nasal colonization and susceptibility profile to antimicrobials in hemodialysis patients using a protocol of seven collections.

  2024cites this paper
• Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy

  2024cites this paper
• Prominent Classes of Antibiotics and their Mechanism of Resistance against Methicillin-Resistant Staphylococcus aureus

  2024cites this paper
• Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis

  2024cites this paper
• Impact of the First Twenty-Four-Hour Area Under the Concentration-Time Curve/Minimum Inhibitory Concentration of Vancomycin on Treatment Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia

  2024cites this paper
• Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis

  2024cites this paper
• Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis

  2024cites this paper
• Antibiotic therapy and prophylaxis of infective endocarditis - A SPILF-AEPEI position statement on the ESC 2023 guidelines.

  2024cites this paper
• Efficacy and Safety of Vancomycin for the Treatment of Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.

  2023cites this paper
• Endocardite infectieuse

  2023cites this paper
• 2023 ESC Guidelines for the management of endocarditis.

  2023cites this paper
• Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

  2022cites this paper
• Growth Arrest of Staphylococcus aureus Induces Daptomycin Tolerance via Cell Wall Remodelling

  2022cites this paper
• Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis

  2022cites this paper
• Improved Neurological Outcome in a Patient With Complicated Mitral Valve Endocarditis Treated With Daptomycin-Rifampin Regimen

  2022cites this paper
• Polycyclic Phenol Derivatives from the Leaves of Spermacoce latifolia and Their Antibacterial and α-Glucosidase Inhibitory Activity

  2022cites this paper
• Uji antibakteri teh hitam dan teh hijau kombucha pada methicillin-resistant Staphylococcus aureus (MRSA)

  2022cites this paper
• Daptomycin and linezolid for severe methicillin-resistant Staphylococcus aureus psoas abscess and bacteremia: A case report and review of the literature

  2022cites this paper
• Automated Susceptibility Testing with Vitek 2 Compared to MicroScan Reduces Vancomycin Alternative Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia.

  2022cites this paper
• Design, synthesis, and antibacterial activity of derivatives of Tryptophanyl-tRNA synthetase inhibitor indolmycin.

  2022cites this paper
• High-Dose Daptomycin and Clinical Applications

  2021cites this paper
• Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection

  2021cites this paper
• Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?

  2021cites this paper
• Combination Ceftaroline and Daptomycin Salvage Therapy for Complicated Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Compared with Standard of Care.

  2021cites this paper
• PK/PD modeling of daptomycin against MRSA and MRSE and Monte Carlo simulation for bacteremia treatment

  2021cites this paper
• Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection

  2021cites this paper
• Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteraemia - A retrospective cohort study

  2021cites this paper
• Molecular epidemiology and phenotypes of invasive methicillin-resistant vancomycin-intermediate Staphylococcus aureus in Taiwan.

  2021cites this paper
• MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against Staphylococcus aureus

  2021cites this paper
• Efficient bioconversion of daptomycin to its nucleus by heterologous expression of deacylase genes in Streptomyces

  2021cites this paper
• Bactericidal and Bacteriostatic Antibiotics

  2021cites this paper
• Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis

  2021influential citation
• Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.

  2020cites this paper
• Influence of the minimum inhibitory concentration of daptomycin on the outcomes of Staphylococcus aureus bacteremia.

  2020cites this paper
• Microbiological Background: Biofilm, Culturing, and Antibiotics

  2020cites this paper
• Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit

  2020cites this paper
• Evaluation of daptomycin-induced cellular membrane injury in skeletal muscle.

  2020cites this paper
• Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study.

  2020cites this paper
• Vancomycin Therapeutic Drug Monitoring in Children: New Recommendations, Similar Challenges.

  2020cites this paper
• Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish

  2020cites this paper
• EVALUATION OF VANCOMYCIN MIC CREEP PHENOMENON IN MRSA ISOLATES FROM CLINICAL SAMPLES

  2020cites this paper
• Seftarolin, Antibiotik Baru dengan Aktivitas Anti-MRSA: Sebuah Kajian Efektivitas, Keamanan, dan Biaya Penggunaan

  2020cites this paper
• Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?

  2019cites this paper
• Acid Sphingomyelinase-Ceramide System in Bacterial Infections.

  2019cites this paper
• Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management

  2019cites this paper
• Advances in the therapy of bacterial bloodstream infections.

  2019cites this paper
• Position statement of the Spanish Association of Paediatrics-Spanish Society of Paediatric Infectious Diseases (AEP-SEIP) on the treatment of Multidrug-resistant bacterial infections

  2019cites this paper
• Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus

  2019cites this paper
• [Position statement of the Spanish Association of Paediatrics-Spanish Society of Paediatric Infectiology (Aep-Seip) on the treatment of multiple drug-resistant bacterial infections].

  2019cites this paper
• Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil

  2019cites this paper
• A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains

  2019cites this paper
• Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents.

  2018cites this paper
• [Possibility of Poor Outcomes after Treatment Using Teicoplanin at the Minimum Inhibitory Concentration of >2 μg/mL in Methicillin-resistant Staphylococcus aureus Bacteremia].

  2018cites this paper
• The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts

  2018cites this paper
• Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients.

  2018cites this paper
• Antimicrobial therapy for methicillin-resistant Staphylococcus aureus

  2018cites this paper
• A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study

  2018cites this paper
• Anti-MRSA Sesquiterpenes from the Semi-Mangrove Plant Myoporum bontioides A. Gray

  2018cites this paper
• Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis

  2018cites this paper
• Alternative Treatment of Methicillin Resistant Staphylococcus aureus Infections: An Update

  2018influential citation
• Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).

  2018cites this paper
• Current and future treatment options for community-associated MRSA infection

  2018cites this paper
• Antimicrobial Resistance in Staphylococci aureus: Mechanisms of Resistance and Clinical Significance

  2017cites this paper
• [Daptomycin for the treatment of infective endocarditis: When do we use it?]

  2017influential citation
• Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety

  2017cites this paper
• Mechanisms of resistance to daptomycin in Staphylococcus aureus.

  2017cites this paper
• [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].

  2017cites this paper
• Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence.

  2017cites this paper
• Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide

  2017cites this paper
• Methicillin-Resistant Staphylococcus aureus: A Pharmacotherapy Primer.

  2017cites this paper
• Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

  2017cites this paper
• Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia

  2017cites this paper
• Is there still a role for vancomycin in skin and soft-tissue infections?

  2017cites this paper
• Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.

  2017cites this paper
• Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin

  2017cites this paper
• Effects of Alterations in Staphylococcus aureus Cell Membrane and Cell Wall in Antimicrobial Resistance

  2017cites this paper
• Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment

  2017cites this paper
• Epidemiología clínica y tratamiento de las infecciones invasoras por staphylococcus aureus resistente a la meticilina

  2017cites this paper
• Mechanisms of resistance to daptomycin in Staphylococcus aureus.

  2017cites this paper
• Early optimization of antimicrobial therapy improves clinical outcomes of patients administered agents targeting methicillin‐resistant Staphylococcus aureus

  2016cites this paper
• Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

  2016cites this paper
• Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.

  2016cites this paper
• Relationship of Vancomycin Minimum Inhibitory Concentration and Treatment Outcomes among Patient with Methicillin-Resistant Staphylococcus aureus Bacteremia: A Four Year Retrospective Study

  2016cites this paper
• Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.

  2016cites this paper
• Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients

  2016cites this paper
• Empirical therapy in Methicillin-resistant Staphylococcus Aureus infections: An Up-To-Date approach.

  2016cites this paper
• CLINICAL OUTCOMES ASSOCIATED WITH TIME TO ANTIMICROBIAL THERAPY CHANGE FROM VANCOMYCIN TO DAPTOMYCIN IN STAPHYLOCOCCAL BACTEREMIA

  2016influential citation
• Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

  2016cites this paper
• Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus

  2016cites this paper